Stroke Prevention in Patients With Atrial Fibrillation

Stroke Prevention in Patients With Atrial Fibrillation, a new systematic review by AHRQ's Effective Health Care Program and the Patient-Centered Outcomes Research Institute, finds blood thinners known as direct oral anticoagulants are as safe and effective as warfarin for treating patients with atrial fibrillation to prevent stroke.

Atrial fibrillation, a common cardiac arrhythmia that increases the risk of stroke, is commonly treated with blood thinners, particularly warfarin. Researchers from 220 journal articles found that dabigatran and apixaban were superior while rivaroxaban and edoxaban were similar to warfarin in the prevention of stroke or systemic embolism.

Select to access the systematic review.

Page last reviewed November 2018
Page originally created November 2018
Internet Citation: Stroke Prevention in Patients With Atrial Fibrillation. Content last reviewed November 2018. Agency for Healthcare Research and Quality, Rockville, MD. http://www.ahrq.gov/news/stroke-atrial-fibrillation.html